Activists Issue Report on HIV Cure Research
Activists from the AIDS Treatment Activists Coalition (ATAC), Project Inform (in San Francisco), and the Treatment Action Group (TAG, in New York City) issued a report summarizing the talks presented at the Community HIV Cure Workshop, which took place in March in Seattle before CROI. The report received funding support from Bionor Pharma, Gilead Sciences, and Merck.
"A cure for HIV will be essential to ending the AIDS pandemic, but science that is focused directly on a cure is still in early stages and will likely require the support of multiple stakeholders to proceed at the fastest pace," the report begins. "Among recent signs of progress, researchers have contributed new insights into where and why HIV persists despite potent ARV therapy." Read the 10-page report.